Is using florbetaben, an amyloid ligand, in PET scanning, accurate in predicting the people with MCI who will progress to develop a dementia? how sensitive and specific is the test? Our review: https://t.co/M8fgQrtECn #dementia #cochrane
RT @CochraneDCIG: Is using florbetaben, an amyloid ligand, in PET scanning, accurate in predicting the people with MCI who will progress to…
Is using florbetaben, an amyloid ligand, in PET scanning, accurate in predicting the people with MCI who will progress to develop a dementia? how sensitive and specific is the test? Our review: https://t.co/M8fgQrtECn #dementia #cochrane
RT @DominicTrepel: New Cochrane evidence: three reviews focusing on 18F PET imaging agents for early diagnosis of Alzheimers disease & othe…
New Cochrane evidence: three reviews focusing on 18F PET imaging agents for early diagnosis of Alzheimers disease & other dementias in people with mild cognitive impairment (MCI): (1) https://t.co/JdFIiL7I9m; (2) https://t.co/L65ADzOBsa; (3) https://t.
RT @CochraneUK: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
RT @CochraneUK: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
RT @CochraneUK: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
RT @CochraneLibrary: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's…
RT @CochraneLibrary: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's…
New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's disease & other #dementias in people with mild cognitive impairment (MCI): (1) https://t.co/eGLMfFe58w; (2) https://t.co/7ZY1QJQqx2;
RT @CochraneAT: New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's dise…
New #CochraneEvidence: a suite of three reviews focusing on 18F PET imaging agents for early diagnosis of #Alzheimer's disease & other #dementias in people with mild cognitive impairment (MCI): (1) https://t.co/lxgu9pSD23; (2) https://t.co/nJlQfmP9JQ;
18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other… https://t.co/2JFPsGLIud
18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other… https://t.co/OYlvBTQCC4